Additionally, the 36-month beta value for SVRA is 0.42. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for SVRA is 78.22M and currently, short sellers hold a 21.96% ratio of that float. The average trading volume of SVRA on May 22, 2025 was 1.02M shares.
SVRA) stock’s latest price update
The stock price of Savara Inc (NASDAQ: SVRA) has plunged by -7.18 when compared to previous closing price of 3.13, but the company has seen a -2.68% decline in its stock price over the last five trading sessions. businesswire.com reported 2025-05-18 that LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced new data in two poster presentations at the ATS International Conference 2025. Data presented were from the Phase 3 IMPALA-2 clinical trial of molgramostim in aPAP and demonstrated that molgramostim reduces surfactant burden and improves health-related quality of life outcomes in patients with aPAP. ATS 2025 Posters Poster Ti.
SVRA’s Market Performance
Savara Inc (SVRA) has seen a -2.68% fall in stock performance for the week, with a -9.63% decline in the past month and a 8.18% surge in the past quarter. The volatility ratio for the week is 6.25%, and the volatility levels for the past 30 days are at 7.00% for SVRA. The simple moving average for the past 20 days is -6.90% for SVRA’s stock, with a -13.16% simple moving average for the past 200 days.
Analysts’ Opinion of SVRA
Many brokerage firms have already submitted their reports for SVRA stocks, with Wells Fargo repeating the rating for SVRA by listing it as a “Overweight.” The predicted price for SVRA in the upcoming period, according to Wells Fargo is $8 based on the research report published on December 20, 2024 of the previous year 2024.
Evercore ISI, on the other hand, stated in their research note that they expect to see SVRA reach a price target of $5, previously predicting the price at $7. The rating they have provided for SVRA stocks is “In-line” according to the report published on November 13th, 2024.
JMP Securities gave a rating of “Mkt Outperform” to SVRA, setting the target price at $8 in the report published on February 15th of the previous year.
SVRA Trading at -1.68% from the 50-Day Moving Average
After a stumble in the market that brought SVRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.05% of loss for the given period.
Volatility was left at 7.00%, however, over the last 30 days, the volatility rate increased by 6.25%, as shares sank -10.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.12% upper at present.
During the last 5 trading sessions, SVRA fell by -2.68%, which changed the moving average for the period of 200-days by -30.05% in comparison to the 20-day moving average, which settled at $3.13. In addition, Savara Inc saw -5.21% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SVRA starting from RAMSAY DAVID A, who purchase 150,000 shares at the price of $2.77 back on Mar 31 ’25. After this action, RAMSAY DAVID A now owns 2,513,642 shares of Savara Inc, valued at $416,250 using the latest closing price.
Lowrance David L, the Chief Financial Officer of Savara Inc, sale 25,000 shares at $3.33 during a trade that took place back on Dec 16 ’24, which means that Lowrance David L is holding 381,005 shares at $83,278 based on the most recent closing price.
Stock Fundamentals for SVRA
Current profitability levels for the company are sitting at:
- -401.31 for the present operating margin
- 0.25 for the gross margin
The net margin for Savara Inc stands at -375.64. The total capital return value is set at -0.62. Equity return is now at value -75.77, with -58.79 for asset returns.
Based on Savara Inc (SVRA), the company’s capital structure generated 0.17 points at debt to capital in total, while cash flow to debt ratio is standing at -3.24.
Currently, EBITDA for the company is -103.07 million with net debt to EBITDA at -0.09. When we switch over and look at the enterprise to sales, we see a ratio of 1885.75. The liquidity ratio also appears to be rather interesting for investors as it stands at 14.91.
Conclusion
In conclusion, Savara Inc (SVRA) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
